The Division of Pharmacoengineering and Molecular Pharmaceutics (DPMP) (https://pharmacy.unc.edu/divisions/dpmp/)https://pharmacy.unc.edu/divisions/dpmp/ in the UNC Eshelman School of Pharmacy invites applications for a 12-month tenure track, Assistant or Associate Professor rank position. The ideal candidate will have research expertise in drug delivery and/or pharmaceutics. We are seeking candidates who have already established or possess the potential to establish a competitive and independent research program. The successful candidate must have a strong track record of publications that demonstrate innovation and an interest in translating novel technologies into real-world impact for patients. Candidates are expected to contribute to the education and training of students in both the Doctoral of Pharmaceutical Sciences (PhD) graduate program and the Doctor of Pharmacy (PharmD) professional program in the UNC Eshelman School of Pharmacy.
The UNC Eshelman School of Pharmacy (https://pharmacy.unc.edu/) is the #1 ranked School of Pharmacy in the nation (U.S. News & World Report) and one of five health science schools (Pharmacy, Nursing, Dentistry, Public Health, and Medicine) at the Chapel Hill campus. The School aspires to be the global leader in pharmacy and is currently ranked #3 in QS World University Rankings for Pharmacy and Pharmacology. We are committed to preparing leaders and innovators to solve the world’s most pressing health care challenges. In 2021, the School released its three-year BEYOND strategic plan (https://faopharmacy.unc.edu/beyond/). The School is home to five academic divisions: Chemical Biology and Medicinal Biology, Pharmacoengineering and Molecular Pharmaceutics, Pharmacotherapy and Experimental Therapeutics, Pharmaceutical Outcomes and Policy, and Practice Advancement and Clinical Education. Specifically, DPMP promotes human health through innovative drug, imaging, and vaccine delivery research and education and aspires to be a diverse and inclusive community of people to accelerate new thinking and ideas in research and education. DPMP’s external research support exceeds $7.9 M annually, and DPMP faculty have successfully spun off over seven biotech companies in recent years. DPMP is home to both the NCI-funded Center of Cancer Nanotechnology Excellence and the Carolina Cancer Nanotechnology T32 Training Program. The School is also home to the Eshelman Innovation Institute (https://unceii.org/), funded by a $100M commitment from Dr. Fred Eshelman, which was launched to forge a game-changing approach to translating bold ideas into real-world impact for patients.
Candidates must have a Ph.D. degree in Chemistry, Engineering, Biochemistry, Pharmaceutics/Pharmaceutical Sciences, or a closely related discipline. The selected candidate will have an appointment in the DPMP and will be eligible for membership in the UNC Lineberger Comprehensive Cancer Center (LCCC), the Carolina Institute for Nanomedicine and the Center for Nanotechnology in Drug Delivery, UNC/NC State Biomedical Engineering, and many other institutes, departments and centers located on UNC campus. Also, UNC is in close proximity to Duke University, Research Triangle Park, and North Carolina State University who often organize and collaborate in efforts with UNC faculty. These efforts include symposia, seminars, and conglomerate groups including North Carolina Biotech Center and NCTracs. Additionally, technology development services are available through Eshelman Innovation Institute, NC Biotech Center, and Carolina Kick Start.
The University of North Carolina at Chapel Hill is an equal opportunity and affirmative action employer. All qualified applicants will receive consideration for employment without regard to age, color, disability, gender, gender expression, gender identity, genetic information, race, national origin, religion, sex, sexual orientation, or status as a protected veteran.
Applications in PDF format including cover letter, CV, detailed statement of research program and interests, and the names and contact information of four references should be submitted https://unc.peopleadmin.com/postings/266256. For inquiries, please contact the search committee chair.
Search Committee Chair: Kristy Ainslie, Ph.D.
Division of Pharmacoengineering and Molecular Pharmaceutics
UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill